Regenxbio RGNX
NASDAQ RGNX
$7.45 -0.02 (-0.27%)
At close: Sep 29, 2026 · 4:00 PM EDT

Regenxbio (RGNX) EPS (Basic) (2014 - 2026)

Updated

Regenxbio's EPS (Basic) came in at $0.43 for Q2 2026, compared with -$1.38 a year earlier.

Analysis

Regenxbio (RGNX) EPS (Basic) (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Regenxbio reported EPS (Basic) of -$3.36; for FY2025, it was -$3.76.

  • Going back by year, EPS (Basic) was -$4.59 in FY2024, -$6.02 in FY2023, -$6.50 in FY2022 and $3.01 in FY2021.
  • The Q2 2026 figure represents the highest quarterly EPS (Basic) since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.30
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.04
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -0.54
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 1.68
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.87
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 4.34
10 Regenxbio 404.61 Mn -528.48 Mn - 0.43
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.43
Dec 31, 2025 -1.30
Sep 30, 2025 -1.20
Jun 30, 2025 -1.38
Mar 31, 2025 0.12
Dec 31, 2024 -1.03
Sep 30, 2024 -1.17
Jun 30, 2024 -1.05
Mar 31, 2024 -1.38
Dec 31, 2023 -1.44
Sep 30, 2023 -1.41
Jun 30, 2023 -1.66
Mar 31, 2023 -1.53
Dec 31, 2022 -1.39
Sep 30, 2022 -1.75
Jun 30, 2022 -1.58
Mar 31, 2022 -1.79
Dec 31, 2021 6.93
Sep 30, 2021 -1.37
Jun 30, 2021 -1.36
API Access

Regenxbio EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=RGNX&period=max&api_key=YOUR_API_KEY